Company Overview

Update
Founded:
February 1, 2012
Employees:
8
Headquarters:
Jena
Funding:
$0.00
Categories:
Biotechnology
Description:
oncgnostics develops IVD tests for screening, therapeutic decision making, and follow-up care in cancer diagnostics.

Detailed Description

Update

oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable in vitro diagnostic (=IVD) tests for screening, therapeutic decisions and follow-up care in cancer diagnostics.

The diagnostic tests developed by oncgnostics are based on DNA regions specifically methylated in precancerous and carcinoma cells. These marker regions are detected using well-established PCR-based technologies, which can be performed in routine molecular diagnostics laboratories with standard equipment. oncgnostics has identified novel markers for detecting cervical precancerous lesions and carcinomas.

Current Team (2)

Update

Funding Rounds (1) - $0.00

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    BioInstrumentezentrum Jena

    Winzelaer Str. 2

    Jena, 07745

    DEU

Images (1)

Update
  • 059303135e2c45a889e1014a88ef97ab